tiprankstipranks
Vishnu Chemicals Limited (IN:VISHNU)
:VISHNU
India Market

Vishnu Chemicals Limited (VISHNU) AI Stock Analysis

Compare
1 Followers

Top Page

IN:VISHNU

Vishnu Chemicals Limited

(VISHNU)

Select Model
Select Model
Select Model
Rating:74Outperform
Price Target:
₹609.00
▲(7.27% Upside)
Action:UpgradedDate:11/28/25
Vishnu Chemicals earns a score of 74, driven primarily by strong financial performance with robust revenue growth and profitability, though tempered by cash flow concerns. Positive technical indicators further support the score with bullish momentum. Valuation is fair but not exceptional, contributing moderately to the overall assessment.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust business expansion and effective market penetration, supporting long-term sustainability and competitiveness.
Negative Factors
Cash Flow Management
Negative free cash flow indicates challenges in cash generation, which could constrain investment capacity and operational flexibility over time.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Strong revenue growth indicates robust business expansion and effective market penetration, supporting long-term sustainability and competitiveness.
Read all positive factors

Vishnu Chemicals Limited (VISHNU) vs. iShares MSCI India ETF (INDA)

Vishnu Chemicals Limited Business Overview & Revenue Model

Company Description
Vishnu Chemicals Limited manufactures and markets chromium and barium chemicals in India. The company offers chrome chemicals, such as sodium dichromate, chromic acid, chrome oxide green, basic chromium sulphate, sodium sulphate, and potassium dic...
How the Company Makes Money
Vishnu Chemicals Limited generates revenue primarily through the sale of its specialty chemicals and intermediates to various industries, including textiles, agriculture, and pharmaceuticals. The company employs a business-to-business (B2B) revenu...

Vishnu Chemicals Limited Financial Statement Overview

Summary
Vishnu Chemicals shows strong revenue growth of 19.6% and improved profitability with a net profit margin of 8.8% in 2025. Balance sheet stability is evident with a debt-to-equity ratio of 0.37 and ROE of 13.7%. However, negative free cash flow of -263.3 million and a low operating cash flow to net income ratio of 0.49 raise liquidity concerns.
Income Statement
85
Very Positive
Balance Sheet
75
Positive
Cash Flow
60
Neutral
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue15.10B14.47B12.09B13.88B10.66B6.72B
Gross Profit4.74B3.58B2.93B4.93B3.86B2.25B
EBITDA2.55B2.44B2.05B2.44B1.60B788.61M
Net Income1.38B1.27B1.01B1.37B813.93M344.95M
Balance Sheet
Total Assets18.27B16.34B13.25B10.51B9.15B7.73B
Cash, Cash Equivalents and Short-Term Investments1.50B817.44M617.07M20.93M27.99M10.47M
Total Debt4.18B3.42B3.19B3.79B3.65B3.36B
Total Liabilities8.27B7.07B6.24B6.37B6.38B5.77B
Stockholders Equity10.00B9.27B7.01B4.14B2.77B1.96B
Cash Flow
Free Cash Flow85.24M-263.28M-528.47M168.85M64.28M129.07M
Operating Cash Flow910.85M615.23M674.98M1.34B897.27M673.66M
Investing Cash Flow-1.42B-1.07B-1.54B-1.18B-811.50M-518.19M
Financing Cash Flow543.59M462.23M881.28M-155.73M-85.66M-191.21M

Vishnu Chemicals Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price567.75
Price Trends
50DMA
509.69
Negative
100DMA
511.47
Negative
200DMA
507.63
Negative
Market Momentum
MACD
-1.94
Negative
RSI
42.45
Neutral
STOCH
49.03
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VISHNU, the sentiment is Negative. The current price of 567.75 is above the 20-day moving average (MA) of 501.30, above the 50-day MA of 509.69, and above the 200-day MA of 507.63, indicating a bearish trend. The MACD of -1.94 indicates Negative momentum. The RSI at 42.45 is Neutral, neither overbought nor oversold. The STOCH value of 49.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VISHNU.

Vishnu Chemicals Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
₹32.89B26.920.05%17.51%33.29%
65
Neutral
₹45.23B-46.403.11%10.35%
63
Neutral
₹5.89B17.610.81%33.39%85.08%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹32.98B211.460.09%8.44%-35.59%
52
Neutral
₹7.17B697.5115.56%2114.71%
45
Neutral
₹19.90B-15.050.43%-11.11%-340.74%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:VISHNU
Vishnu Chemicals Limited
488.60
38.24
8.49%
IN:BHAGERIA
Bhageria Industries Ltd.
135.00
-18.77
-12.21%
IN:BODALCHEM
Bodal Chemicals Limited
56.96
-5.01
-8.08%
IN:GUJALKALI
Gujarat Alkalies & Chemicals Ltd.
615.85
47.82
8.42%
IN:NEOGEN
Neogen Chemicals Ltd.
1,250.20
-404.79
-24.46%
IN:TIRUMALCHM
Thirumalai Chemicals Limited
165.05
-71.40
-30.20%

Vishnu Chemicals Limited Corporate Events

Vishnu Chemicals Appoints New Independent Director
Nov 18, 2025
Vishnu Chemicals Limited has announced the appointment of Mr. Srivari Chandrasekhar as a Non-Executive Independent Director, effective from November 18, 2025. This strategic appointment is based on the recommendation of the Nomination and Remunera...
Vishnu Chemicals Reschedules Investor Meetings to October 29
Oct 24, 2025
Vishnu Chemicals Limited has announced the rescheduling of its Analyst/Institutional Investor Meetings to October 29, 2025, which will be held physically in Mumbai. The company has assured that no unpublished price-sensitive information will be sh...
Vishnu Chemicals Schedules Investor Meetings in Mumbai
Oct 21, 2025
Vishnu Chemicals Limited has announced a schedule for meetings with analysts and institutional investors, set to take place on October 27, 2025, in Mumbai. These meetings, which will occur from 10 am to 6 pm, are part of the company’s compli...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 28, 2025